Head-to-head · WeighScore
Ivologist vs Lttl
The verdict
Too close to call — both grade 66.1/100 (C).
Ivologist and Lttl land on the same WeighScore, so neither clears the other on our six graded dimensions. Ivologist sits one line higher on the board (#202 vs #204) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ivologist | Lttl |
|---|---|---|
| WeighScore | 66.1/100 | 66.1/100 |
| Grade | C | C |
| Scorecard rank | #202 | #204 |
| Semaglutide | $145/mo (compounded) | $199/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $279/mo (all doses, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #202 · C
Strengths
- LegitScript certified
- All 50 states coverage
- No monthly contracts, memberships, or autodrafts
- Over 20,000 patients served
- Both semaglutide and tirzepatide available
Where it loses points
- No legal entity name or physical address disclosed on site
- Broader platform — not a GLP-1 specialist
- $25 deposit required to book the provider consultation (unclear whether it is credited toward the program)
Graded #204 · C
Strengths
- Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout
- Flat dose pricing: 'Same price at every dose,' so moving to a higher dose does not raise the monthly bill
- States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
- Microdose line prices low-dose semaglutide or tirzepatide at $149/mo month-to-month for people sensitive to side effects
- Oral ODT semaglutide offered for members who want to avoid injections
Where it loses points
- Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)
- The advertised 'Plans start at $129/mo' is the 12-month prepay rate; true month-to-month is $199 semaglutide and $279 tirzepatide
- No public list of states served — eligibility depends on where unnamed 'partner providers are licensed'
- Site banner promises 'Prescribed and shipped within 48 hours' while the shipping policy states 2-5 business days to process plus 3-7 to deliver
- Medications cannot be returned or refunded once they ship from the pharmacy
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.